Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC
Clinical trial NCT04147728 · UNKNOWN
Trial details
- NCT number
- NCT04147728
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-24
- Primary completion
- 2021-12-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.